Navigation Links
Osteo Science Foundation to Support Scientific and Clinical Research in Oral and Maxillofacial Surgery
Date:10/21/2013

ROSEMONT, Ill., Oct. 21, 2013 /PRNewswire-USNewswire/ -- Dr. Peter Geistlich, chairman of the board of Geistlich Pharma, has established the Osteo Science Foundation to advance hard and soft tissue regeneration in the area of oral, cranial and maxillofacial surgery through high quality basic and clinical research, and education that leads to improved outcomes and quality of life for patients.

(Logo: http://photos.prnewswire.com/prnh/20111219/DC25244LOGO)

Creation of the Osteo Science Foundation was announced at the OMS Faculty Section Business Meeting convened during the 2013 AAOMS Annual Meeting in Orlando, FL, October 7-12. Dr. Jay P. Malmquist, Chairman of the Foundation Board, states that, "Advancements in regenerative medicine are continuously improving clinical outcomes in the area of oral, cranial and maxillofacial surgery. The Osteo Science Foundation seeks to maximize these advancements by supporting scientific and clinical research and education relating to the most effective surgical techniques and clinical use of biomaterials and biologics."

In pursuit of its objective to encourage scientific and clinical research in the area of regenerative medicine, the Osteo Science Foundation has initiated a call for abstracts with a submission deadline of December 1, 2013. The first grants are expected to be awarded in July 2014, with funding of up to $50,000 per project and a maximum duration of two years. Dr. Malmquist noted that there is no proscribed cap on the number of projects that may be accepted for the grants. He further stated that by 2015, the number of grant cycles will be increased to two per year, and the first educational symposium will be held.

"AAOMS is excited to work with the Osteo Science Foundation to encourage research in the area of hard and soft tissue regeneration in the oral, cranio and maxillofacial surgical area," said AAOMS President Dr. Miro A. Pavelka. "Biomaterials and biologics hold tremendous promise for the treatment we provide our patients. This is truly the future of oral and maxillofacial surgery in the United States."

Joining Dr. Malmquist on the Osteo Science Foundation Board are oral and maxillofacial surgeons Dr. Alan S. Herford, chairman and program director of the Department of OMS Residency Program at Loma Linda University School of Dentistry, and Dr. Peter K. Moy, professor, Department of Oral and Maxillofacial Surgery, UCLA School of Dentistry.

Saving Face | Changing Lives® — The American Association of Oral and Maxillofacial Surgeons (AAOMS), the professional organization representing more than 9,000 oral and maxillofacial surgeons in the United States, supports its fellows' and members' ability to practice their specialty through education, research and advocacy. AAOMS fellows and members comply with rigorous continuing education requirements and submit to periodic office anesthesia evaluations.

For further information check the AAOMS Website at www.aaoms.org.


'/>"/>
SOURCE American Association of Oral & Maxillofacial Surgeons
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Ampio Pharmaceuticals, Inc. Announces Additional Positive Results for Ampion(TM) in Osteoarthritis of the Knee Clinical Trial
2. Cellular Biomedicine Group Announces Positive Interim Results from Phase I/IIa Clinical Trial for Treatment of Knee Osteoarthritis (KOA)
3. Ampio Pharmaceuticals, Inc. Announces Positive Results for Ampion in Osteoarthritis of the Knee Clinical Trial
4. Increasing Prevalence of Osteoarthritis and Preference for Minimally Invasive Procedures to Drive Arthroscopy Devices Market Growth
5. RNL BIO Co. Ltd. Files IND To Commence Phase II Clinical Trial Of RNL-JointStem For Osteoarthritis In The United States
6. Ampio Pharmaceuticals Completes Enrollment in Run-In SPRING study of Ampion in Osteoarthritis of the Knee
7. Musculoskeletal Network covers the Osteoarthritis Research Society International Conference
8. Nearly 30 Percent of Women Fail to Pick Up New Prescriptions for Osteoporosis, Kaiser Permanente Study Finds
9. Nuovi dati rivelano il crescente problema dellosteoporosi in Europa
10. PharmaPoint: Osteoporosis - US Drug Forecast and Market Analysis to 2022
11. PharmaPoint: Osteoporosis - India Drug Forecast and Market Analysis to 2022
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/31/2017)... July 31, 2017  Diplomat Pharmacy, Inc. (NYSE: DPLO), has ... Michigan by Crain,s Detroit Business . ... public companies by three-year revenue growth. This year,s edition measures ... To view the complete list, visit crainsdetroit.com/awards/fast_50/2017 .  ... an incredible triumph," said Phil Hagerman , CEO and ...
(Date:7/31/2017)... Surgical, developer of ground breaking surgical navigation technologies, announced today ... support its strategic sales plan in Maryland ... Surgical has entered into an exclusive sales representative agreement with ... those markets. ... Spartan Medical Purchases 7D Surgical Technology ...
(Date:7/28/2017)... July 28, 2017 EnvoyHealth, a Diplomat company, has ... program for CleverCap LITE, a technology designed to improve ... deliver innovative health technology solutions and services that help ... CleverCap LITE offers medication monitoring and ... cover: Records date ...
Breaking Medicine Technology:
(Date:8/18/2017)... (PRWEB) , ... August 18, ... ... d/b/a Quick International, LLC (“Quick”), a highly specialized asset-light logistics provider of ... entered into a definitive agreement to purchase Unitrans International Corporation, a division ...
(Date:8/18/2017)... ... August 18, 2017 , ... As an ... an educational webinar, they will present the line of epMotion automated liquid handling ... easy you can automate everyday pipetting tasks. , Ideal for scientists and lab ...
(Date:8/18/2017)... , ... August 18, 2017 , ... ... financial planning services to communities in east Texas, is launching a regional charity ... Foundation. , Founded in 1991, the Pediatric Brain Tumor Foundation (PBTF) has raised ...
(Date:8/18/2017)... ... August 18, 2017 , ... The Golseth Agency, a Texas based insurance ... is spearheading a regional charity campaign organized to provide support to Christina Upchurch and ... this year, Christina and her children returned from out of town to find her ...
(Date:8/18/2017)... Raton (PRWEB) , ... August 18, 2017 , ... Alcovit, ... continuing to ramp up its marketing efforts with its product now available through Jet.com. ... remedy to the public. The effervescent powdered drink is designed to quickly detox the ...
Breaking Medicine News(10 mins):